CIK 0001339970
- Non-accelerated filer
- Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203435077
- Phone
- +1 858-731-8389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 245,000 shares at an average $0.42 ($103,247)
- 4 Open-market buy Director bought 147,225 shares at $0.54 ($79,796)
- 4 Open-market buy Chief Financial Officer bought 64,000 shares at an average $0.83 ($52,855)
- 4 Open-market buy Chief Financial Officer bought 26,000 shares at $0.73 ($19,055)
- 4 Open-market buy Director bought 42,749 shares at an average $0.74 ($31,461)
- 4 Open-market buy Director bought 164,411 shares at an average $0.74 ($121,573)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise See Remarks acquired 3,333 shares (option exercise)
- 4 Open-market buy Director bought 150,000 shares at $1.00 ($149,445)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 3,209,316 shares at an average $0.93 ($2,999,056)
Page 8 of 17 · 329 filings